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Abstract
Some studies showed that recombinant follicle stimulating hormone (r-FSH) administration 
without LH supplementation has a good success rate on in vitro fertilization (IVF). However, LH 
role in IVF has been controversial. This study was conducted to evaluate the association between 
serum LH levels at the time of hCG injection and clinical pregnancy during IVF. This retrospective 
study included 136 patients underwent long protocol IVF from January 2005 to December 2009 in 
Yasmin Clinic, Cipto Mangunkusumo Hospital, Jakarta. The controlled ovarian hyper-stimulation 
protocol used in this study was gonadotropin-releasing hormone (GnRH) agonist and r-FSH.  
Serum LH level was measured on the day of hCG administration and the outcome evaluated was 
the clinical pregnancy following IVF cycles. There were 32 IVF cycles resulted in pregnancy out of 
136 cycles (23.5%). There was significant difference between serum LH levels on the day of hCG 
administration and clinical pregnancy outcome (p=0.036). LH serum level cut-off value of ≥1.050 
IU/l was the best value to predict pregnancy outcome with 62.5% sensitivity, 59.4% specificity, 
83.3% positive predictive value, and 32.76% negative predictive value. It was concluded that there 
was an association between serum LH levels at the time of hCG injection and clinical pregnancy 
during IVF.
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Hubungan Kadar LH saat Penyuntikan hCG dengan Kejadian 
Kehamilan pada Fertilisasi In vitro 
Abstrak
Pemberian follicles stimulating hormone rekombinan (r-FSH) tanpa suplementasi LH 
memiliki tingkat keberhasilan fertilisasi in vitro (FIV) yang baik namun, peran LH pada FIV masih 
kontroversial. Tujuan penelitian ini adalah untuk mengevaluasi hubungan antara kadar serum 
LH pada hari penyuntikan hCG dengan kehamilan klinis selama FIV. Penelitian retrospektif ini 
melibatkan 136 perempuan yang menjalani FIV siklus pertama dengan protokol panjang mulai 
bulan Januari 2005 sampai Desember 2009 di klinik Yasmin, Rumah Sakit dr. Cipto Mangunkusumo, 
Jakarta. Protokol hiperstimulasi ovarium yang digunakan adalah agonis gonadotropin-releasing 
hormone (GnRH) dan r-FSH. Kadar LH serum diukur pada hari pemberian hCG dan outcome 
penelitian yang dievaluasi adalah kehamilan klinis. Kehamilan terjadi pada 32 siklus FIV dari 136 
siklus (23,5%). Terdapat  perbedaan bermakna antara kadar serum LH pada hari penyuntikan hCG 
dengan kehamilan klinis (p = 0,036). Titik potong kadar serum LH ≥1,050IU/l adalah nilai terbaik 
untuk memprediksi hasil kehamilan dengan sensitivitas 62,5%, 59,4% spesifisitas, nilai prediksi 
83,3% positif, dan nilai prediksi 32,76% negatif. Disimpulkan bahwa terdapat hubungan antara 
kadar serum LH pada hari penyuntikan hCG dengan kehamilan klinis selama FIV.
Kata kunci: siklus IVF, kadar LH serum, pemberian hCG
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Introduction
LH is a glycoprotein hormone that plays an 
important role in the process of steroidogenesis. 
The concept of two cell – two gonadotropin explains 
that granulosa and theca cell stimulation by LH and 
FSH results in intra- follicular estradiol production 
that affects follicle maturation.1 Optimal level of 
LH is necessary for ovum maturation, fertilization 
process, and embryonic development. If LH level 
is too low, it will inhibit follicle maturation and if it is 
too high (e.g premature LH surge), it will increase 
the risk of miscarriage. 2-4
IVF is an infertility treatment that has the 
highest clinical pregnancy rate, which is around 20-
50%. In women with fallopian tube abnormalities 
(e.g. obstruction and infection), IVF is the best 
option. Two main factors determining the success 
of IVF are the quality of embryos and endometrial 
receptivity. The quality of embryos are determined 
by various factors including the reproductive 
hormones level (e.g. FSH, estradiol, LH, prolactin, 
progesterone).5
One of the developments in IVF methods is the 
use of r-FSH. Studies results showed that the use 
of r-FSH alone without LH supplementation has 
good IVF success rate. Thus, LH role in IVF is still 
controversial. The optimal LH level for IVF success 
has not been determined.3,6 This study aims to 
investigate the relationship between LH levels 
during hCG injection with IVF outcome. The results 
are expected to optimize the IVF success rate. 
Methods
This retrospective study was conducted on 
136 infertility patients who underwent IVF cycles in 
Yasmin Clinic, dr. Cipto Mangunkusumo Hospital, 
Jakarta, Indonesia from January 2005 to December 
2009. The inclusion criterion was infertile patients 
who completed the long protocol IVF cycles. 
Patients with history of previous ovarian surgery 
were excluded. 
Controlled ovarian hyper-stimulation protocol 
used in this study was the long protocol. GnRH 
agonist 0.5 mg was administered during mid-
luteal phase for 14 days. Afterwards, the dose was 
reduced to 0.25 mg and 225 IU r-FSH was added 
for 10-12 days. Recombinant human chorionic 
gonadotropin (hCG) 250 mg was administered 
if ultrasonography (USG) examination showed 
follicular diameter ≥20 mm or endometrial thickness 
≥10 mm. The hormone hCG was given one or two 
days before ovum pick up (OPU). On the day of 
hCG injection LH serum level was measured by 
ELISA using Immulite machine from Siemens. 
Clinical pregnancy was defined as the 
presence of the gestational sac inside the uterus 
in three to four weeks after OPU. The data was 
analyzed using SPSS software 16.00. Student’s 
t-test was used to compare LH serum levels on the 
day of hCG injection with IVF outcome (i.e. clinical 
pregnancy) for data with normal distribution. Mann-
Whitney U-test was used to analyze data without 
normal distribution. P-value of <0.05 is considered 
statistically significant. Area under the receiver 
operating characteristic curve (AUC) and odds ratio 
(OR) were calculated to determine the power of the 
analyzed variables.
Results
There were 136 subjects with age varied 
between 22-48 years old who underwent IVF cycle 
and fulfilled the inclusion criteria (Table 1). There 
were 136 IVF cycles resulting in 32 pregnancies 
(23.5%). Most subjects were experiencing primary 
infertility (97.1%).
Based on Kolmogorov Smirnov normality 
test, it was shown that the data did not have 
normal distribution therefore Mann-Whitney U-test 
was used to determine the relationship between 
LH levels on the day of hCG injection and the 
occurrence of pregnancy. We found a significant 
correlation between LH levels on the day of hCG 
injection and the occurrence of pregnancy (p 
=0.036)
Based on analysis receiver operating 
characteristic (ROC), the threshold value of LH 
levels on the day of hCG injection to determine 
the clinical pregnancy was ≥1.050 IU/l. LH levels 
≥1.050 IU/l has a sensitivity of 62.5%, specificity 
of 59.4%, positive predictive value of 83.3%, and 
32.76% negative predictive value in determining 
the clinical pregnancy. LH levels ≥1.050 IU/l on the 
day of injection of hCG association with pregnancy 
rate was almost 0.4 times lower than that of LH 
levels <1.050 IU/l (OR 0.411; AUC 0.623; Figure 1).
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Table 1. Demographic Data of Pregnant and Not Pregnant IVF Patients 
Variable Pregnant (n=32) Not pregnant (n=104) p
Age (year) 33,31 34,90 0.065
Infertility type
   Primary infertility
   Secondary infertility
27 (84.4%) 
5 (15.6%)
101 (97.1%)
3 (2.9%)
0.007
Duration of infertility (year) 7.22 7.05 0.825
Causes of infertility (female factor)
Tubal factor
Endometriosis
Ovulation disfunction
Other factors
Idiopatic
Causes of infertility(male factor)
   Azoospermia
   Severe Oligospermia 
   Other factors
8 (25%)
0 (0%)
3 (9.4%)
4 (12.5%)
17 (53.1%) 
1 (3.1%)
13 (40.6%)
18 (56.3%)
21 (20.2%)
14 (13.5%)
7 (6.7%)
12 (11.5%)
50 (48.1%)
18 (17.3%)
31 (29.8%)
55 (52.9%)
0.292
0.108
Insemination method
   ICSI
   Conventional
   Combination (ICSI+conventional)
31 (96.9%)
0 (0%)
1 (3.1%)
85 (81.7%)
1 (1%)
18 (17.3%)
0.106
FSH basal hormone level (IU/l)
AMH basal hormone level (µg/ml)
Progesteron level on the day of hCG injection (ng/ml)
Estradiol level on the day of hCG injection (pg/ml)
LH level on the day of hCG injection 
6.33
4.43
1.41
2.47
1.07
7.19
4.64
1.61
2.14
1.57
0.211
0.755
0.755
0.137
0.02
Endometrial thickness on the day of hCG injection 11.61 10.76 0.048
Total mature follicular  (≥17mm) on  OPU 8.13 7.38 0.306
Total mature oocyte (2nd metaphase oocyte) 7.81 6.81 0.167
A total of 58 subjects (42.6%) had LH levels <1.050 IU/l after stimulation. A total of 59.4% subjects with 
LH levels <1.050 IU/l showed clinical pregnancy 
compared to 40.6% subjects with LH levels ≥1.050 
IU/l (Table 2). There was significant difference in 
term of  clinical pregnancy between patients with 
LH level ≥1.050 IU/l and those with LH level <1.050 
IU/l (p = 0.029)
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Table 2. Pregnancy Outcomes According to LH Level on the Day of hCG Injection 
LH (IU/l) Pregnant (%) Not pregnant (%)
<1,050 19 cycles (59.4) 39 cycles (37.5)
≥1,050 13 cycles (40.6) 65 cycles (62.5)
Total 32 cycles (100.0) 104 cycles (100.0)
Figure 1. Sensitivity and SLH Level on hCG Injection with IVF Outcomes 
Discussion
Gonadotropic hormones, LH and FSH, work 
synergistically in the process of follicular development 
and maturation.3 Nevertheless, the role of LH in 
follicle stimulation during follicular phase in patients 
undergoing IVF cycle is still being debated. According 
to Chappel et al7 study LH had little role in the process 
of follicle maturation during the follicular phase. 
Moreover, the optimal level of LH that supports IVF 
success have not yet been determined.3
This study determined LH levels threshold value 
of ≥1.050 IU/l on the presence of clinical pregnancy 
based on ROC analysis. LH level ≥1.050 IU/l had a 
62.5% sensitivity, 59.4% specificity, 83.3% positive 
predictive value, and 32.76% negative predictive value 
in determining the pregnancy outcomes. This threshold 
value is equivalent to the threshold values in researches 
conducted by Westergaard et al8 which was less than 
0.5 IU/l and by Balasch et al9 who determined the 
threshold value of LH levels less than 1, 0.7, and 0.5 
IU/l. The comparison between sensitivity, specificity, 
negative predictive value, and positive predictive value 
were not observed  in those previous researches.
A total of 58 subjects (42.6%) experienced a 
decrease in LH concentration to <1.050 IU/l on the 
day of hCG injection. To the best our knowledge, 
there is not any other research that measured 
the levels of LH on the day of hCG injection. 
Westergaard et al.8 conducted a study with 200 
normo-gonatodotropic subjects who underwent IVF 
with GnRH agonist and r-FSH. In their study 49% 
of subjects had of LH levels of <0.5 IU/l on mid-
follicular phase. Another study was carried out by 
Balasch et al9 with 144 subjects who underwent IVF 
with 0.1 mg GnRH agonist (i.e. triptorelin acetate) 
and 300-450 IU r-FSH. As many as 31%, 15%, and 
17% subjects had higher LH levels of <1, ≤0.7, and 
<0.5IU/l respectively at mid-follicular phase.
A total of 59.4% subjects with LH levels <1.050 
IU/l showed clinical pregnancy compared to 40.6% 
subjects with LH levels ≥ 1.050 IU/l. The association 
with pregnancy rate when LH level of ≥ 1.050 IU/l 
on the day of hCG injection is almost 0.4 times 
lower than when LH levels <1.050 IU/l (OR 0.411; 
AUC 0.623; (Figure 1)). 
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Previous researches regarding LH level used 
different threshold values with varied results. 
Some researches suggested that low level of LH 
was associated with lower incidence of pregnancy. 
The study by Westergaard et al8 stated that the 
incidence of pregnancy in subjects with low LH 
levels were 30% compared to 34% in subjects 
with normal LH levels (> 0.5 IU/l). Another study 
by Balasch et al9 showed that 20% of subjects with 
LH levels <1 IU/l experienced a clinical pregnancy 
compared to 52% of subjects with LH levels> 
1 IU/l. Esposito et al1 conducted a study to 166 
normo-gonadotrophic subjects who underwent 
IVF cycles with leuprolide acetate and r-FSH. The 
study showed that clinical pregnancy occurred in 
40% of subjects with LH levels < 3mIU/mL and in 
43% subjects with LH levels ≥ 3 mIU/mL.
A different result was reported by Humaidan et 
al10 who conducted a study on 207 patients using 
LH threshold value of ≤ 0.5 IU/I LH, from 0.51 to 
1.0 IU/l, from 1.01 to 1.5 IU/l, and>1.5 IU/l. In their 
study, the most optimal outcome was observed in 
group with LH threshold value between 0.51 to 1.5 
IU/l. Patients whose LH levels were higher than 
that had lower incidence of pregnancy. 
In this research we found a significant correlation 
between LH level and pregnancy outcome (p = 
0.036). In addition, there was significant different 
in term of clinical pregnancy between subjects with 
LH levels ≥ 1.050 IU/l and subjects with LH levels 
<1.050 IU/l (p = 0.029). Similar studies by Esposito 
et al,1 Westergaard et al,8 and Balasch et al9 found 
no relationship between LH levels and pregnancy 
as the outcome of IVF.
Differences between the results of this study 
compared to the previous researches were due to 
several reasons. Firstly, there are differences in the 
dose of GnRH agonist and r-FSH in the controlled 
ovarian hyperstimulation protocol used in each 
study. Secondly, the different GnRH regiment 
used is considered to be responsible for the 
various effect of GnRH on ovarian steroidogenesis 
suppression. Thirdly, time of measurement and the 
threshold value of LH levels applied were varied in 
previous researches.3,8,9
Conclusion
LH concentration threshold value of ≥ 1.050 
IU/l has 62.5% sensitivity, 59.4% specificity, 83.3% 
positive predictive value, and 32.76% negative 
predictive value in determining pregnancy 
outcomes. There was significant correlation 
between LH levels on the day of hCG injection 
and the occurrence of pregnancy (p=0.036). 
In addition, there was significant difference in 
pregnancy incidence between subjects with LH 
levels ≥ 1.050 IU/l and subjects with LH levels 
<1.050 IU/l (p = 0.029). LH concentration on the 
day of hCG injection can be useful in predicting 
incidence of pregnancy as the outcome of IVF.
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